Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by carduon Jul 06, 2011 4:49pm
284 Views
Post# 18803220

RE: RE: RE: RE: RE: management shift

RE: RE: RE: RE: RE: management shift"In my humble opinion that ONC is still around after 10 years of study speaks volumes"

Actually, they've been around for 13 years.

 "Poor managment is the reason my portfolio s*cks" tune?"

My portfollio is doing quite well. In the nine years I've been in this stock by playing my trading shares and keeping tight my long shares I've managed to get my average cost down to $2.17 per share which I intend to cash in when the ship comes home, which I've said many times on this board ( i.e., long before you came on board).

"Since when is a chronology a function of maturity or accumulated wisdom?"

It is a universal accepted fact that with age comes wisdom and maturity (unless,of course, life has taught you nothing).

I respect most members on this board because they are, for the most part, confident and knowledgeable in the science and are not afraid to criticize management when it is justified, as is their right.

Bullboard Posts